PHASE 1/2A STUDIES WITH OCR-002 (ORNITHINE PHENYLACETATE); OPTIMIZED DOSING REGIMEN WITH AN AMMONIA SCAVENGER FOR TREATMENT OF HEPATIC ENCEPHALOPATHY | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

HERO ID

2997389

Reference Type

Journal Article

Title

PHASE 1/2A STUDIES WITH OCR-002 (ORNITHINE PHENYLACETATE); OPTIMIZED DOSING REGIMEN WITH AN AMMONIA SCAVENGER FOR TREATMENT OF HEPATIC ENCEPHALOPATHY

Author(s)

Hassanein, T; Kittrelle, JP; Cato, J; Fischer, L; Anderson, K

Year

2012

Is Peer Reviewed?

Yes

Journal

Journal of Hepatology
ISSN: 0168-8278
EISSN: 1600-0641

Volume

Page Numbers

S240-S241

Web of Science Id

WOS:000303241301167